Invention Grant
- Patent Title: Compositions and methods of using nintedanib for improving glaucoma surgery success
-
Application No.: US16131945Application Date: 2018-09-14
-
Publication No.: US10335408B2Publication Date: 2019-07-02
- Inventor: Jinsong Ni , Rong Yang
- Applicant: Cloudbreak Therapeutics, LLC
- Applicant Address: US CA Irvine
- Assignee: Cloudbreak Therapeutics, LLC
- Current Assignee: Cloudbreak Therapeutics, LLC
- Current Assignee Address: US CA Irvine
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61P27/06 ; A61K9/08 ; A61K45/06 ; A61K9/00 ; A61K9/107
Abstract:
Compositions and methods of using nintedanib for improving the success rate of glaucoma filtration surgery are disclosed herein. Nintedanib can be used alone or in combination with an anti-metabolite drug in a topical or implant eye formulation.
Public/Granted literature
- US20190015409A1 COMPOSITIONS AND METHODS OF USING NINTEDANIB FOR IMPROVING GLAUCOMA SURGERY SUCCESS Public/Granted day:2019-01-17
Information query
IPC分类:
